Breckenridge Pharmaceutical issued a nationwide US recall of propranolol on Monday. The recall covers one lot of 60mg hydrochloride extended-release capsules due to potential metal contamination.
The affected medicine comes in bottles of 100 capsules. Patients and pharmacies can identify it using these details:
- Lot number: PK25110035
- National Drug Code: 51991-817-01
- Expiry date: May 2029
Breckenridge urged consumers with the affected product to stop taking capsules from that lot. Consumers should promptly contact their healthcare provider for medical advice and replacement instructions. Consumers should also return unused capsules to the pharmacy that dispensed them.
Anyone experiencing problems potentially linked to the medicine should contact a healthcare professional. Patients and healthcare providers can also report adverse reactions or product-quality concerns through the US Food and Drug Administration’s (FDA) MedWatch programme.
Consumers can contact Qualanex, the company’s recall service provider, on 1-855-736-0807 with questions about the recall.
Breckenridge instructed pharmacies, wholesalers and retailers to inspect their stock, quarantine affected supplies and stop dispensing or distributing them.
Adare Pharma Solutions manufactured the capsules. These capsules reached wholesalers and pharmacies across the United States between October 26 and November 4.
Read More: Cetirizine Tablet Recall Covers Four Lots Nationwide
Breckenridge warned that metal contamination could cause cuts to soft tissue in the mouth, oesophagus, stomach or intestines. However, as of its November 16 announcement, the company had received no reports of adverse events it considered related to the recall.
According to Breckenridge, the recalled batch shared intermediate material with a separate lot that contained metal contamination. The company said that the separate lot never reached the market.